FTC files amicus brief challenging REMS patent listings in FDA’s Orange Book
Regulatory NewsMary Ellen Schneider
North AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsMary Ellen SchneiderNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy